Coenzyme Q


Journal

BMC pharmacology & toxicology
ISSN: 2050-6511
Titre abrégé: BMC Pharmacol Toxicol
Pays: England
ID NLM: 101590449

Informations de publication

Date de publication:
07 04 2021
Historique:
received: 04 12 2020
accepted: 16 03 2021
entrez: 8 4 2021
pubmed: 9 4 2021
medline: 15 12 2021
Statut: epublish

Résumé

Arsenic poisoning affects millions of people. The inorganic forms of arsenic are more toxic. Treatment for arsenic poisoning relies on chelation of extracellularly circulating arsenic molecules by 2,3-dimecaptosuccinic acid (DMSA). As a pharmacological intervention, DMSA is unable to chelate arsenic molecules from intracellular spaces. The consequence is continued toxicity and cell damage in the presence of DMSA. A two-pronged approach that removes extracellular arsenic, while protecting from the intracellular arsenic would provide a better pharmacotherapeutic outcome. In this study, Coenzyme Q Group one represented the control; the second group was treated with NaAsO Administration of CoQ Findings from this study demonstrate that CoQ

Sections du résumé

BACKGROUND
Arsenic poisoning affects millions of people. The inorganic forms of arsenic are more toxic. Treatment for arsenic poisoning relies on chelation of extracellularly circulating arsenic molecules by 2,3-dimecaptosuccinic acid (DMSA). As a pharmacological intervention, DMSA is unable to chelate arsenic molecules from intracellular spaces. The consequence is continued toxicity and cell damage in the presence of DMSA. A two-pronged approach that removes extracellular arsenic, while protecting from the intracellular arsenic would provide a better pharmacotherapeutic outcome. In this study, Coenzyme Q
METHODS
Group one represented the control; the second group was treated with NaAsO
RESULTS
Administration of CoQ
CONCLUSIONS
Findings from this study demonstrate that CoQ

Identifiants

pubmed: 33827703
doi: 10.1186/s40360-021-00484-z
pii: 10.1186/s40360-021-00484-z
pmc: PMC8028750
doi:

Substances chimiques

Antidotes 0
Arsenites 0
Chelating Agents 0
Protective Agents 0
Sodium Compounds 0
Ubiquinone 1339-63-5
sodium arsenite 48OVY2OC72
Succimer DX1U2629QE
coenzyme Q10 EJ27X76M46
Glutathione GAN16C9B8O

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19

Références

Int J Mol Sci. 2019 Jul 11;20(14):
pubmed: 31336801
Bioinorg Chem Appl. 2015;2015:751013
pubmed: 26170775
PLoS One. 2016 Mar 11;11(3):e0151225
pubmed: 26967897
Life Sci. 2005 Sep 16;77(18):2324-37
pubmed: 15964026
Oxid Med Cell Longev. 2016;2016:5818479
pubmed: 27190575
Parasitol Int. 2019 Aug;71:106-120
pubmed: 30981893
J Prev Med Public Health. 2014 Sep;47(5):245-52
pubmed: 25284195
Indian J Clin Biochem. 2013 Apr;28(2):185-8
pubmed: 24426207
BMC Vet Res. 2017 Jun 5;13(1):157
pubmed: 28583123
Oncotarget. 2017 Apr 4;8(14):23905-23926
pubmed: 28108741
Altern Med Rev. 1998 Jun;3(3):199-207
pubmed: 9630737
Basic Clin Pharmacol Toxicol. 2012 May;110(5):449-59
pubmed: 22117535
Methods Enzymol. 2005;401:468-83
pubmed: 16399403
PLoS One. 2014 Jan 22;9(1):e86445
pubmed: 24466103
Front Physiol. 2018 Feb 05;9:44
pubmed: 29459830
Free Radic Biol Med. 2015 Aug;85:174-82
pubmed: 25916185
Clin Ter. 2012;163(5):e293-302
pubmed: 23099976
Biomolecules. 2020 Feb 04;10(2):
pubmed: 32033229
Postgrad Med J. 2003 Jul;79(933):391-6
pubmed: 12897217
Curr Protoc Toxicol. 2009;42(431):4.31.1-4.31.6
pubmed: 25419261
Arch Toxicol. 2001 Nov;75(9):531-7
pubmed: 11760813
J Epidemiol. 2012;22(2):144-50
pubmed: 22277791
Biometals. 1995 Apr;8(2):111-6
pubmed: 7734923
Nat Rev Mol Cell Biol. 2019 May;20(5):303-320
pubmed: 30745579
Oxid Med Cell Longev. 2008 Oct-Dec;1(1):39-45
pubmed: 19794907
Nat Immunol. 2009 Mar;10(3):241-7
pubmed: 19221555
Heliyon. 2020 Feb 19;6(2):e03431
pubmed: 32149198
Int J Mol Sci. 2017 Apr 24;18(4):
pubmed: 28441753
Nutr J. 2016 Jul 25;15(1):71
pubmed: 27456681
Br J Haematol. 2006 Feb;132(3):349-58
pubmed: 16409300
Nat Protoc. 2006;1(6):3159-65
pubmed: 17406579
Circ Res. 2020 Apr 10;126(8):1061-1085
pubmed: 32271679
Ann Glob Health. 2014 Jul-Aug;80(4):303-14
pubmed: 25459332
J Appl Toxicol. 2011 Mar;31(2):95-107
pubmed: 21321970
Adv Cancer Res. 2014;122:103-41
pubmed: 24974180
Sci Rep. 2017 Aug 15;7(1):8253
pubmed: 28811612
Antioxid Redox Signal. 2011 Feb 1;14(3):403-13
pubmed: 21091355
J Appl Toxicol. 2020 May;40(5):552-566
pubmed: 31867774
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8892-7
pubmed: 9671775
Front Physiol. 2020 Feb 07;11:64
pubmed: 32116774
Biochem Med (Zagreb). 2016;26(2):178-93
pubmed: 27346963
J Environ Biol. 2007 Apr;28(2 Suppl):359-65
pubmed: 17929751
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
Toxicology. 1995 Jan 6;95(1-3):167-75
pubmed: 7825183
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15956-60
pubmed: 19805235
Biofactors. 2008;32(1-4):179-83
pubmed: 19096114
Arch Toxicol. 2013 Jun;87(6):969-79
pubmed: 22811022
J Pharmacol Pharmacother. 2010 Jul;1(2):94-9
pubmed: 21350617
Heliyon. 2020 Sep 14;6(9):e04917
pubmed: 32984611
Arch Toxicol. 2008 Jul;82(7):453-9
pubmed: 18046539
J Immunotoxicol. 2016 Sep;13(5):686-93
pubmed: 27416995
mBio. 2018 Aug 14;9(4):
pubmed: 30108172
Int J Environ Res Public Health. 2019 Aug 13;16(16):
pubmed: 31412628
Pharmacognosy Res. 2016 Mar;8(Suppl 1):S26-30
pubmed: 27114688
BMC Pharmacol Toxicol. 2015 Jun 05;16:15
pubmed: 26044777
Phytother Res. 2005 Jan;19(1):23-8
pubmed: 15799004
Environ Sci Pollut Res Int. 2018 Aug;25(24):23946-23953
pubmed: 29948670
Int J Biol Sci. 2007 Apr 05;3(4):257-62
pubmed: 17479158
Int J Med Sci. 2018 Feb 12;15(5):425-429
pubmed: 29559830
Br J Haematol. 2009 Mar;144(5):798-9
pubmed: 19036092
Nagoya J Med Sci. 2017 Feb;79(2):167-177
pubmed: 28626252
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19666-7
pubmed: 24225851
Toxicol Rep. 2018 May 26;5:704-713
pubmed: 29992094
Environ Health. 2013 Sep 02;12(1):73
pubmed: 24004508
Environ Health. 2011 Jul 08;10:64
pubmed: 21740555
Food Chem Toxicol. 2018 Aug;118:849-860
pubmed: 29944914

Auteurs

Victoria K Mwaeni (VK)

Department of Biochemistry and Biotechnology, Technical University of Kenya, P. O. Box 52428, Nairobi, 00200, Kenya.

James N Nyariki (JN)

Department of Biochemistry and Biotechnology, Technical University of Kenya, P. O. Box 52428, Nairobi, 00200, Kenya.

Ngalla Jillani (N)

Institute of Primate Research, P.O. Box 24481, Karen, Nairobi, 00502, Kenya.

George Omwenga (G)

Department of Biochemistry, Microbiology and Biotechnology, Kenyatta University, P.O. Box 43844-00100, Nairobi, Kenya.

Mathew Ngugi (M)

Department of Biochemistry, Microbiology and Biotechnology, Kenyatta University, P.O. Box 43844-00100, Nairobi, Kenya.

Alfred Orina Isaac (AO)

Department of Pharmaceutical Sciences and Technology, Technical University of Kenya, P. O. Box 52428, Nairobi, 00200, Kenya. alfred.orina@tukenya.ac.ke.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH